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"Greatness is not in where 
we stand, but in what 
direction we are moving. We must sail sometimes with the 
wind and sometimes against it - but sail we must, and not drift, 
or lie at anchor. • 
- Oliver Wendell Holmes 
A Holiday Greeting 
On behalf of your medical staff leadership, Drs. Rae-Grant, 
Caccese and myself, I would like to extend our sincere wishes 
for a warm and meaningful Holiday Season - one that 
emphasizes the importance of our relationships with family and 
friends. This is a valuable opportunity to strengthen the bonds 
that make our society a strong fabric, and ultimately make us 
strong and stable individuals. In some ways now, we 
recognize the values that our country holds in common more 
than those in which we agree to differ. Make this a very 
special Holiday Season by reinforcing what is important to us 
all. 
Appreciate our freedoms. Savor and enjoy the customs, the 
gatherings, the heritage and that which is our way of life at this 
holiday time. Recognize and appreciate those who touch our 
lives and wish them well. 
We extend our greetings at this holiday time to all members of 
the LVHHN extended medical family. We thank you for your 
contributions and value working with you. 
"America at its best matches a commitment to principle with a 
concern for civility. A civil society demands from each of us 
good will and respect, fair dealing and forgiveness. Civility is 
not a tactic or a sentiment. It is the determined choice of trust 
over cynicism, of community over chaos. And this 
commitment, if we keep it, is a way to shared 
accomplishment.· 
- George W. Bush - Inaugural Address- 1/20/01 
(Continued on Page 2) 
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First the Good News 
J. Michael Eakin has been elected to the Pennsylvania 
Supreme Court, Giving the Prospect of Tort Reform a 
Significant Boost. 
Eakin narrowly defeated fellow Superior Court Judge Kate 
Ford Elliott to give Republicans control of the state's highest 
court for the first time in three decades, reported the 
Associated Press. Eakin was supported by physicians through 
a grassroots fundraising campaign in the belief that his election 
to the Pa. Supreme Court would give it a majority of strict 
constructionists who would be less likely to strike down tort 
reform provisions passed in the Pa. Legislature, which has 
been a serious obstacle to tort reform in Pa. Eakin has also 
told physicians that he is aware that the medical liability 
problem is exacerbated by reimbursements that are 
dramatically lower than they are in surrounding states and that 
the problem is causing physicians to leave the state and to 
retire early, as well as creating a significant physician 
recruitment problem. (Associated Press, November 7, 2001) 
We would like to thank all members of the LVH medical 
staff who contributed to the campaign of Judge Mike 
Eakin for Pennsylvania Supreme Court. The contest was a 
victory for tort reform and a step in the right direction. He 
was supported by PMS and HAP. 
The judge is a self-effacing jurist with a sense of humor. 
At his fundraiser, he mentioned that a State Superior 
Court judge has to be careful not to take himself too 
seriously. I found him refreshingly self-effacing, and very 
savvy about the legal status of the Pennsylvania 
malpractice crisis. It is with renewed optimism that we 
now contact our state senators and representatives to 
help their constituents with this nagging problem. This is 
a problem that is boiling over in our sister state, West 
Virginia. (See below) 
Try not. There is no try. Do or do not. 
-The Wisdom ofYoda 
West Virginia's Charleston Area Medical Center is 
preparing to halt surgeries and shut down its Emergency 
Room by the end of year unless lawmakers find a solution 
to the state's looming malpractice crisis. 
The hospital's physicians, many of whom are facing non-
renewal of their medical liability insurance, are preparing 30-
day notices to patients that their services will no longer be 
available unless the Legislature solves West Virginia's medical 
malpractice insurance crisis by the end of November, reported 
the Charleston Daily Mail. West Virginia Senate Finance 
Chairman Oshel Craigo said that he expects hospitals and 
physicians around the state to be making similar preparations 
and noted that lawmakers consider Nov. 30 to be the "drop-
dead" date for working out a solution to the situation, which 
could include having the state extend malpractice insurance to 
physicians as a stopgap measure, the Daily Mail added. 
(Charleston Daily Mail, November 14, 2001) 
Eighteen Delaware County Orthopedic Surgeons, the large 
majority of the county's total, announced they will no 
longer perform surgery or respond to trauma calls 
beginning January 1 due to unaffordable medical liability 
insurance. 
Testifying at a Pennsylvania House Insurance Committee 
meeting, the Premier Orthopaedic & Sports Medicine 
Associates physicians noted that their primary malpractice 
premiums would increase up to 100 percent for 2002, with total 
costs projected at $130,000 per surgeon, compared with 
$65,000 per surgeon just two years ago. The physicians 
pointed to the increasing number and size of medical 
malpractice jury awards in southeastern Pa. as a reason for 
the steady climb in insurance costs. (Pennsylvania 
Orthopaedic Society, 10/ 24/01.) 
Although not as high in Lehigh County as in Philadelphia, 
the malpractice premiums for our orthopedic colleagues 
are high and have risen about 50% this year. The 
manpower numbers for the high profile (high malpractice 
premium) specialties, which are orthopedics, 
neurosurgery, and ob-gyn, are down 10% across 
Pennsylvania and down 20% in Philadelphia. 
A day without sunshine is like night. 
I have kleptomania, but when it gets bad, I take something for it. 
Length of Stay and at LVHHN •... Capacity Issues in 
OR, ED, and on med-surg floors 
The utilization of hospital beds has been cyclic in the past. We 
are now struggling with capacity constraints, which seem to be 
related to availability of med-surg beds at a time when our 
length of stay across the network has slowly risen. We 
certainly realize that a contributing factor might be delay in 
taking an in-patient to the OR for a necessary procedure. 
(Continued on Page 3) 
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However, the LOS has gone up for non-surgical patients as 
well. When the hospital beds are full, we cannot move patients 
out of the Emergency Department (which may require the ED 
to go on "divert"} or out of the recovery room (which in tum 
backs up patients leaving the operating rooms). We note that 
both outcomes are challenges to quality patient care. 
Bed management (Lisa Romano) has been alert to this issue 
and monitors admissions and discharges daily in an effort to 
anticipate and manage this problem. 
In the past, the LVH medical staff has been responsible and 
responsive to this issue. Again, we are asking for your help 
and cooperation in reducing the length of LVH hospital stay. 
Please wori<: with the discharge planners to arrange the best 
care for your patients. 
"Yosemite Pari<: is a place of rest, a refuge ... None can escape 
its charms, its natural beauty cleans and warms like a fire, and 
you will be willing to stay forever in one place like a tree. • 
-John Muir, 1895 
Anesthesia Anyone? 
At a recent meeting of the Department of Surgery, there was a 
frank and productive discussion about the theme of OR 
efficiency- start times, room turnover, avoiding delays, etc. 
The issue of anesthesia providers was discussed openly by Dr. 
Tom McLoughlin, and the meeting was well attended by the 
surgeons and OR administrative leadership. The outcome is 
an increased focus on efficiency - one that will take the 
combined will of all members of the OR team and creative 
incentives for each component. 
Room captains? Productivity recognition and awards? 
Suggestions from the OR staff about reducing room turnover 
times? Room flow analysis? (sounds Urologic, I admit} 
We are asking all surgeons to start their rooms on time, see 
their patients (if necessary} before the case, and contribute to 
OR efficiency. 
The best way to forget all your troubles is to wear tight shoes. 
You Say the Door is Locked? 
You may have noticed that more hospital access doors now 
require your photo ID badge. This is actually a continuation of 
a LVHHN security policy, which has been in place for the past 
several years. E. Gerald Kresge, Director of Security, has 
asked all members of the medical staff to be patient with the 
increased emphasis on identification of everyone on campus. 
Remember that the ultimate goal is safety and security for 
patients and staff alike. 
Golfer. "Well, caddy, how do you like my game?" 
Caddy: "Very well, Sir. But personally, I prefer golf. • 
Edward M. Mullin, Jr., MD 
Medical Staff President 
New Chairperson of OB/GYN Named 
Effective September 24, L. Wayne Hess, MD, was named the 
new Chairperson of the Department of Obstetrics and 
Gynecology. 
Dr. Hess comes to Lehigh Valley Hospital and Heatth Networi<: 
from the University of Missouri-Columbia Health Sciences 
Center in Columbia, Missouri, where he served as Professor 
and Chairman of the Department of Obstetrics and 
Gynecology. His prior experience includes major leadership 
positions at the University of Mississippi in Jackson, Miss., and 
the United States Naval Hospitals in Portsmouth, Va., and 
Bethesda, Md. 
Dr. Hess received his medical degree from the Medical 
College of Virginia. He completed his internship at the U.S. 
Naval Hospital in Portsmouth, Va., where he also completed 
his Obstetrics and Gynecology residency. He then completed 
a fellowship in Maternal-Fetal Medicine at Walter Reed Army 
Medical Center in Washington, D.C. 
Dr. Hess is board certified in Obstetrics and Gynecology and in 
Maternal-Fetal Medicine. He has had a distinguished career 
as a clinician, educator, researcher, and leader. Dr. Hess has 
relocated to the Lehigh Valley along with his wife, Darla, a 
cardiologist and family. 
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Contact Your U.S. Senators! 
Urgent Action Needed to Fix Medicare 
Physician Payment Update 
Senator James Jeffords (1-VT) and Senator John Breaux (D-
LA) have offered a bill in the U.S. Senate to dramatically 
improve the physician Medicare payment update for 2002. 
The bill isS. 1660, the"Medicare Physician Payment Fairness 
Act of 2001. • The Jeffords-Breaux bill would change the 
payment update for 2002 from -5.4 percent to -0.9 percent. 
Unless Congress intervenes, payments for all Medicare 
services provided by all physicians and other health care 
professionals will be 5.4 percent lower next year. 
Please contact Pennsylvania's U.S. Senators as soon as 
possible to urge them to co-sponsor and support the Jeffords-
Breaux "Medicare Physician Payment Fairness Act of 2001," 
s. 1660. 
To read more about U.S. Senate Bill1660 and for a quick 
method to send your Senator an e-mail message or to create 
and print a letter, follow the "ACTION ALERT!" at 
www.capwiz.com/pamedsoc <http://www.capwiz.com/pamedsoc> 
Recognizing the Impaired Health Care 
Professional 
The impaired health care professional- physician, nurse, 
ancillary provider- is one who is unable to practice his or her 
profession with reasonable skill, care and diligence as well as 
safety to patients because of an emotional disorder, substance 
abuse or some other personal problem. 
A recent study by the National Institute for Occupational Health 
and Safety indicates that health care professionals may have a 
higher than average risk of developing debilitating personal 
problems. Research suggests that 12-14 percent of all 
practicing physicians are, or will become, impaired during their 
careers. 
This may be due, in part, to the fact that many health care 
professionals are so idealistic and perfectionistic and work-
addicted in the name of healing everyone else that they don't 
know how to handle their personal and emotional lives. 
The impaired professional will exhibit subtle personality 
changes as the problem or disorder worsens. Mood swings 
may be common, ranging from irritability, outbursts of anger, 
and paranoia to sudden euphoria and hyperactivity. 
In the office or hospital, the impaired professional may have 
frequent schedule disruptions, behave inappropriately toward 
patients, staff and colleagues, have complaints made by 
patients or staff regarding his/her unusual behavior, and be 
absent frequentiy due to "illness." 
The impaired physician may display abnormal behavior during 
rounds, give inappropriate orders and be unavailable for the 
emergency room or call. His/her charting may deteriorate and 
handwriting change. Allegations by staff may occur regarding 
inappropriate behavior. 
Regardless of profession, additional symptoms of impairment 
include: 
);;> Deterioration in physical appearance and 
grooming 
);;> Multiple physical signs and complaints 
);;> Withdrawal from friends and colleagues and from 
involvement in community activities 
);;> Embarrassing behavior at social functions 
);;> Poor judgment 
);;> Inappropriate conversations with patients 
);;> Neglect of commitments and responsibilities 
);;> Decreasing quality of patient care 
If you are concerned about a possibly impaired physician, you 
are encouraged to contact the appropriate Chairperson of the 
physician's department, a member of Troika, or John W. Hart, 
Vice President, at (610) 402-8980~ In the case of physicians, 
appropriate referrals may be made to the Physician Assistance 
Program or the Physician Health Program of the Pennsylvania 
Medical Society, of which the hospital and medical staff are 
major contributors. 
Please remember- all contacts will be kept confidential. 
? ? ? Mystery Medical Staff Member ? ? ? 
? Born in Wilkes-Barre, Pa. 
? Received a Bachelor of Science degree at 
King's College 
? Received Medical degree from Jefferson 
Medical College of Thomas Jefferson 
University 
? Surgical internship at New Rochelle Hospital 
Medical Center 
? Residency in Public Health at SUNY at Stony 
Brook 
? Joined the Medical Staff in 1997 
? Drives a Green Chrysler Sebring 
? Enjoys gardening 
Give up? Please see Page 13 for the answer. 
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How Do You Achieve Patient !!R! > Listen-really listen-to your patients. 
Satisfaction? > Make a connection with your patients when you speak 
Four LVHHN Physicians Check In With with them. 
Service Excellence Tips > Have enough administrative support in your office so you 
have enough time to spend with patients. 
What's the key to patient satisfaction? Four LVHHN 
physicians who have received high marks from patients and 
are active in service excellence initiatives had the following to 
say: 
Vincent R. Lucente, MD 
Chief, Division of Gynecology 
"We don't want to just satisfy patients, we want to wow 
them-truly and honestly treat them as if they are a family 
member. The doctor-patient relationship is a very special 
one and the cornerstone is effective communication-
careful listening and talking in layman's terms." 
Tips 
> Build a team that embraces patient satisfaction every day. 
> Be sincere in customer service and demonstrate that with 
a smile on your face. If you're not enjoying your work, 
patients will know. 
> Be honest in scheduling patients so you're not squeezing 
people in-or you're just setting yourself up for failure. 
Wayne F. McWilliams, MD 
Division of Generallntemal Medicine 
"Be as empathic as possible. Put yourself in their shoes 
and try to understand what they're feeling. Then you can 
understand their specific needs and develop a treatment 
plan that makes them feel comfortable." 
Tips 
> Make good eye contact. 
> Make sure there is a caring tone in your voice so they 
know that you understand what they're going through. 
> Manage your time carefully from the time you enter the 
exam room. Use an internal clock to move as efficiently 
through the appointment as possible. 
Charles D. Peters, MD 
Division of Generallntemal Medicine 
"Sit and listen to your patients because they usually can 
give you information that will help you understand what is 
wrong with them and how to treat them. Listening is more 
important than some of the technology we have, and it's 
something we try to instill in our medical residency 
program." 
Prodromes A. Ververeli, MD 
Chief, Division of Orthopedic Surgery 
"I try to relate to patients and families at their level of 
understanding. This includes explaining complex medical 
issues in understandable terms and analogies. The 
patient and family need to understand what is going on in 
order to have realistic expectations for their health care." 
Tips 
> Explain clinical details in simple terms. 
> Make sure the patient and family understand the issues by 
asking them to review what you have explained. 
> Touch on a personal note at each visit. Make notes in 
their chart about any upcoming anniversaries, vacations or 
graduations, and then inquire about it at the next visit. 
The Medical Letter 
As most of you know from my previous announcement, The 
Medical Letter is now on-line on the LVH Intranet. It can be 
accessed by going to Clinical, then scrolling down to The 
Medical Letter and double clicking. 
In order to search and pull up articles from The Medical Letter. 
you will need to have Adobe Acrobat installed on the hard 
drive of your workstation. Not all of the hospital workstations 
have Acrobat installed on their hard drives. The installation of 
this software is easy and is available on the LVH network. 
Follow the procedure !Jelow to install Adobe Acrobat: 
If you have trouble looking up articles from The Medical Letter: 
• Click on START (bottom left of the screen) 
• Go to PROGRAMS - double click 
• See if Adobe Acrobat is there 
• If it is - you're all set to access The Medical Letter 
• If it isn't, proceed as follows: 
• Go to the icon on your desktop called Win Install 
Interactive 
• Double Click on the icon 
• You will see a list of programs which can be installed 
from the network 
• Click on Adobe 4. 05 
(Continued on Page 6) 
Medical Staff Progress Notes December, 2001 ~!,L Volume 13, Number 12 Page 6 
(Continued from Page 5) 
• 
• 
Follow the instructions which will take you through the 
installation process 
After installation, you will need to re-boot the 
computer to begin to use Acrobat to access articles 
from The Medical Letter 
Hopefully, this will help to solve a simple problem which has 
made it difficult to get the full benefit from having The Medical 
Letter "on-line". 
David M. Caccese, MD 
News from CAPOE Central 
By now, many of you have made rounds on 6B and have seen 
the implementation of computer based Medication 
Administration and Vital Sign charting by the staff. The staff 
has done a wonderful job of adapting to the new processes 
and using the wireless devices. We have learned a 
tremendous amount from the implementation on nu, and 
clearly many of the processes have been improved. This 
change has an impact on the physicians and physician 
extenders. On 6B and nu, the most recent medication 
records and vital signs are now on the computer. The 
expectation is that the medical staff, housestaff, and physician 
extenders will use the computer (either wireless handheld 
devices or desktop computers) to view vital signs and 
medications for their patients. It is not the role of the nursing 
staff or the Administrative Partners to print this information out 
for the rounding teams. 
You may have noticed various physicians carrying wireless 
devices with them in the hospital. We are piloting different 
configurations (carrying cases and keyboards) with various 
groups. The goal is to find the configuration that works best for 
each group. The advantage of using a wireless device is that 
the user remains logged in while using the device. This 
eliminates the need to log in and log out on the desktop 
computers on each unit during rounds. Thus, a physician can 
check patient information for any patient from any location in 
the hospital. The wireless device can also be used to read e-
mail and look up clinical information on the Internet. 
Please use the wireless devices when you are on nu and 6B. 
Given the availability of access points throughout both the 
Cedar Crest & 1-78 and LVH-Muhlenberg campuses, wireless 
access can be realized by anyone who cares for patients at 
these locations. If you or your group would like a wireless 
device to use on rounds on a continuous basis, please contact 
me or one of the Physician Educators- Lynn Corcoran-Stamm 
at (61 0} 402-1425, Kimbertee Szep at (61 0} 402-1431, or 
Carolyn Suess at (610} 402-1416. 
Donald Levick, MD, MBA 
(610} 402-5100 7481 (Pager} 
Tumor Boards Reinstated at LVH-M 
Since the arrival of John P. Ford, MD, Associate Chief, 
Division of Hematology-Medical Oncology, Tumor Boards have 
been reinstated at LVH-Muhlenberg. The first of these was 
held on November 7 with a review of three cases preceded by 
a presentation on breast cancer by Elizabeth A. Dellers, MD, 
Associate Chief, Division of Anatomic Pathology (LVH-M}. The 
conference was well attended, with representatives from the 
various campuses and community physicians. 
Tumor Boards at LVH-Muhlenberg will continue to be held 
every Wednesday, from Noon to 1 p.m. in the O.R. Conference 
Room on the second floor of the hospital. With Dr. Ford as 
moderator, the format will be that of a "combined" tumor board 
with cases not restricted to a specific organ site. Each session 
begins with a short presentation and discussion of a current, 
controversial topic in medicine, particularly in oncology. 
Physicians wishing to participate as presenters are 
encouraged to contact Maria Dreher, CTR, who coordinates 
the Tumor Boards at (484) 884-5809 on Tuesdays and 
Wednesdays, or at (610} 402-0518 on Mondays, Thursdays, 
and Fridays. Cases for review are identified primarily by 
review of pathology reports by the tumor registry. A listing of 
newly identified cases (diagnosed and/or treated at LVH-
Muhlenberg} is compiled and three cases are selected for 
presentation. Physicians wishing to have cases reviewed can 
request their addition to the agenda either by calling Maria 
Dreher or by impromptu requests at the meeting. 
The agenda for Tumor Boards will be posted one week prior to 
presentation on the Lehigh Valley Hospital TAO e-mail system. 
It can be accessed by clicking first on "Bulletin Boards" and 
then on "Tumor_Board_Agenda". It is flagged with an identifier 
to distinguish it from Tumor Boards held at LVH-CC. 
Tumor Boards are open to both clinicians and non-clinicians 
alike. Nursing staff, social workers, technicians, and those 
with an interest in and/or involvement in cancer care are 
invited to attend. Continuing education credits will be offered 
as part of attendance, and sign-in sheets will be provided. 
For more information, contact Maria Dreher at one of the 
numbers listed above. 
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Dorothy Rider Pool Health Care Trust • $20,000 to the Department of Surgery for the development 
Awards $3.6 Million to Lehigh Valley of a cardiothoracic surgery database. The resources will 
help stimulate the development of a comprehensive 
Hospital and Health Network cardiovascular database that includes clinical, 
demographic, and outcomes data for patients who have 
The Trustees of the Dorothy Rider Pool Health Care Trust 
have awarded seven grants totaling $3,595,000 to Lehigh 
Valley Hospital and Health Network {LVHHN). The seven 
grants include: 
• $2,700,000 over five years to the Department of Medicine 
for enhancement of the medical education/residency 
program. The resources will be used to help further the 
growth and development of the education and research 
activities within the department. Funds will also be used 
to support three fellowships at L VH in the areas of 
cardiology, pulmonary/critical care and hematology-
oncology. 
• $225,000 over three years to the Department of Obstetrics 
and Gynecology for discretionary use by the new chair of 
the department, L. Wayne Hess, MD. 
• $200,000 over three years for the development of an 
anticoagulation service. The anticoagulation service will 
incorporate a multidisciplinary team to provide the 
opportunity for improved patient outcomes through fewer 
complications and enhanced patient education. 
• $180,000 over three years to the Department of 
Emergency Medicine for the Emergency Medicine 
Residency Program. The funds will be used to develop 
and enhance the resources necessary to train future 
emergency physicians and support continuing education 
of the faculty. 
• $150,000 over three years to the Department of 
Emergency Medicine for the sexual assault response 
team {SART). The goal of the program is to develop a 
consistent, comprehensive, expert, compassionate 
approach to care for victims of sexual assault. The project 
seeks to continue as well as enhance the existing sexual 
assault forensic examiner {SAFE) program funded by Pool 
Trust in 1998. The current plans include creating a Sexual 
Assault Response Team to improve care by enhancing 
equipment and services across the three sites - Cedar 
Crest & 1-78, 17th & Chew, and LVH-Muhlenberg locations. 
Services will also be provided for children under age 12. 
• $120,000 over three years for the Physician Leaders in 
the Lehigh Valley program. The resources will be used to 
provide ongoing assistance in furthering to develop 
physician skills as leaders and mentors as health care 
practitioners in the community. Physician Leaders in the 
Lehigh Valley is a leadership development program for the 
LVHHN medical staff. The program was started in 1997 
and has been supported by the Pool Trust since its 
inception. 
procedures performed either in the operating room or in 
the cardiac catheterization laboratory by cardiothoracic or 
vascular surgeons or by medical cardiologists. The 
complete cardiovascular database/registry will be 
designed to integrate with and to complement the capacity 
of LVH's Regional Heart Center. 
Coding Tip of the Month 
Diabetes Mellitus - Controlled or 
Uncontrolled 
It is important to let coders know whether 
a diabetic patient is controlled or 
uncontrolled. For example, when a 
diabetic becomes hypoglycemic because 
of overexercise or starvation and passes 
out with a blood sugar of 40, indicate 
whether you consider that uncontrolled. 
When a patient is admitted with sepsis 
from a urinary tract infection and a blood 
sugar of 650, please document whether 
you consider that uncontrolled. After 
surgery, a patient taking varying doses of 
insulin based on blood sugar 
determination is not likely uncontrolled but 
rather being controlled with sliding scale. 
If the uncontrolled diabetes takes extra 
work to maintain homeostasis, then 
writing uncontrolled in the record will allow 
the coder to pick this important 
information up. Remember if it is not 
written, it cannot be coded. 
Radiology's Interpretation of "STAT" 
STAT is interpreted as "do the study as 
soon as possible" NOT "read the study as 
soon as possible." Physicians who wish an 
immediate wet reading should order the test 
"STAT with immediate wet read." 
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Congratulations! 
Joel M. Glickman, DMD, Division of Endodontics, was 
awarded Fellowship in the American College of Dentists on 
October 12 during their Annual Meeting and Convocation in 
Kansas City, Mo. The American College of Dentists was 
founded in 1920 to recognize dentists who have made 
significant contributions to the advancement of dentistry. 
Papers, Publications and Presentations 
Julie A. Dostal, MD, Vice Chairperson (LVH), Department of 
Family Practice, presented on "Bridge Over Troubled Water: 
Understanding the Cultural Chasm at the End of Life in 
Nursing Homes" at the NAPCRG's 291h Annual Meeting which 
was held in Halifax, Nova Scotia, in October. At the same 
meeting, William L. Miller, MD, Chairperson, Department of 
Family Practice, co-presented a full-day workshop titled 
"Multimethod Approaches to Researching Practice Settings." 
The workshop focused on the collection and analysis of 
multimethod data designed to understand family practices from 
the ground up through intensive direct observation of the 
practice environment and patient care. Dr. Miller also co-
presented a workshop - "Literature Review as Qualitative 
Research: An International, Collaborative, Participatory Search 
for the Value of Family Practice." In addition, Dr. Miller co-
authored two articles - "Practice Jazz: Understanding Variation 
in Family Practices Using Complexity Science" and 
"Understanding Practice from the Ground Up" - which were 
published in The Journal of Family Practice. 
Several members of the Department of Family Practice also 
presented at the 20th Annual Society of Teachers of Family 
Medicine Northeast Region Meeting, which was held in Mystic, 
Conn., in October. 
):;> Eamon C. Armstrong, MD, gave a poster presentation 
titied "Morning POEMs" Teaching Point of Care, Patient 
Centered EBM." Dr. Armstrong along with Brian Stello, 
MD, presented on "Evidence-Based Medicine Starts and 
Ends with the Patient • Dr. Stelle also had a paper 
presentation - "Just-in-Time" Clinical Practice: Resident 
Use of Informatics during the Clinical Encounter." 
):;> A paper presentation was given by Dr. Dostal titled 
"Screening for Health Risk Indicators: Domestic Violence 
and Tobacco Use." In addition, Jennifer Neuendorff, 
DO, Family Practice resident, and Dr. Dostal gave a paper 
presentation titled "Bringing Health to Adolescents 
Through E-COPC." 
~ Sarah Nicklin, MD, gave a paper presentation -
"Observation of Resident Skill in Promoting the Doctor-
Patient Relationship." 
Mark A. Gittleman, MD, Division of General Surgery, recently 
was an invited speaker at the Annual Clinical Congress of the 
American College of Surgeons held October 7 to 10, in New 
Orleans, La. His topics included "Image Guided Breast 
Biopsy" and "lnterventional Breast Ultrasound." 
Geoffrey G. Hallock, MD, Division of Plastic Surgery, recentiy 
attended the Inaugural Congress of the World Society for 
Reconstructive Microsurgery in Taipei, Taiwan. He presented 
a paper on "Further Nomenclature Simplification of Compound 
Flaps." In addition, he was a discussant on a panel describing 
"Perforator Flaps." Both are unique approaches in an attempt 
to improve the versatility of free tissue transfers. Of special 
interest during the conference was an "on-site" visit to the 
microsurgery unit in Taipei where they have a 24-bed intensive 
care unit specifically for microsurgical reconstruction patients 
only. This is needed to accommodate the almost 1 ,000 cases 
of replantation and free flaps that the Chinese do on an annual 
basis, and represents probably one of the largest such case 
volume of any institution in the world. 
Gregory R. Harper, MD, PhD, Physician in Chief, Cancer 
Services, co-conducted two workshops during the annual 
Keystone Breast Cancer Coalition Conference on the STAR 
Breast Cancer Prevention Trial held October 18, in Harrisburg, 
Pa. The STAR trial compares tamoxifen and raloxifene in the 
prevention of breast cancer among high-risk, post-menopausal 
women. 
lndru T. Khubchandani, MD, Lester Rosen, MD, John J. 
Stasik, MD, and Robert D. Riether, MD, all members of the 
Division of Colon and Rectal Surgery, co-authored an article-
"Rectal Prolapse: A Search for the "Best Operation• - which 
appeared in the July issue of The American Surgeon 
(2001 ;67:622-627). 
Michael K. Kim, MD, Division of Otolaryngology-Head & Neck 
Surgery, gave a presentation in November at the American 
Thyroid Association National Meeting held in Washington, D.C. 
His talk was titied "Morbidity Following Central Compartment 
Reoperation for Recurrent Thyroid Cancer.· 
Vincent R. Lucente, MD, Chief, Division of Gynecology, co-
authored five poster presentations at the recent American 
Urogynecology Society meeting held October 25 to 28 in 
Chicago, Ill. He was also the senior author on a video 
presentation regarding the Laparoscopic Burch procedure, 
which was presented by T. Russell Horton, MD, Chief 
Resident, Department of Obstetrics and Gynecology. In 
addition, he was an invited speaker for a panel discussion 
regarding the Tension Free Vaginal Tape (TVT) for Female 
Incontinence. Dr. Lucente presented the U.S. Experience. 
While in Chicago, he was the invited visiting professor for 
Grand Rounds at Northwestern University Hospital where he 
presented "New Concepts in Female Lower Urinary Tract 
Infections." 
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(Continued from Page 8) 
Marisa A. Mastropietro, MD, Section of Pelvic Reconstructive 
Surgery, had an oral presentation at the recent American 
Urogynecology Society meeting titled, "Pelvic Organ Prolapse: 
A Range of Normal Values." 
Gary G. Nicholas, MD, Chief, Division of Vascular Surgery, 
and Program Director, General Surgery Residency, was invited 
to present at surgical grand rounds at Mercy Hospital in 
Scranton, Pa., on September?. Dr. Nicholas' presentation-
"Ischemic Stroke: Current Therapy• - provided the audience 
with information on the use of lytic therapy for ischemic stroke, 
indicators for carotid endarterectomy, and the value of non-
invasive testing with ischemic stroke treatment. 
Michael D. Pasquale, MD, Chief, Division of General Surgery 
and Division of Trauma-Surgical Critical Care, co-authored an 
article titled, "Multi-institutional Experience with the 
Management of Superior Mesenteric Artery Injuries, • which 
appeared in the October issue of The Journal of the 
American College of Surgeons (2001 :193:354-366). 
Upcoming Seminars, Conferences and 
Meetings 
Emergency Medicine Grand Rounds 
Emergency Medicine Grand Rounds are held on Thursdays, 
beginning at 8 a.m., at alternate locations. Topics for 
December will include: 
December 6 ·Auditorium, Cedar Crest & 1·78 
~ Pediatric Case Review- St. Luke's Emergency Medicine 
Residency 
~ "Pulmonary Edema: From Blue as a Squid to Happy as a 
Clam• and "Children are Not Just Small Adults and Other 
Pediatric Myths" 
~ Tintinalli Club 
December 13 • 4th Floor Conference Room, LVH·M 
~ M&M 
~ Lower Extremity Injuries 
~ Physician Wellness 
~ Medical Command Tapes 
December 20 • 4th Floor Conference Room, LVH·M 
~ CO Poisoning 
~ Domestic Violence 
~ Alcohol Emergencies 
~ Tintinalli Club 
December27 
~ No Grand Rounds - Happy Holidays! 
For more information regarding Emergency Medicine Grand 
Rounds, please contact Dawn Yenser in the Department of 
Emergency Medicine at (484) 884-2888. 
Medical Grand Rounds 
Medical Grand Rounds are held every Tuesday beginning at 
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest 
& 1-78, and via videoconference in the First Floor Conference 
Room at Lehigh Valley Hospital-Muhlenberg. Topics to be 
discussed in December will include: 
~ December 4 - "Hometown Defense by Division of 
Infectious Diseases and Infection Control" 
~ December 11 -"Asthma and the Athlete• 
~ December 18- "Update in Sleep Medicine" 
Medical Grand Rounds will resume on January 8, 2002. For 
more information, please contact Diane Biernacki in the 
Department of Medicine at (610) 402-5200. 
Department of Pediatrics 
Pediatric conferences are held every Tuesday beginning at 8 
a.m., in the Auditorium of Lehigh Valley Hospital, Cedar Crest 
& 1-78. Topics to be discussed in December include: 
~ December 4 -"Imaging the Pediatrics Abdomen" 
~ December 11 - "The Muscular Dystrophies -An Update" 
~ December 18- "Case Presentation· 
~ December 25 - No Conference 
For more information, please contact Kelli Ripperger in the 
Department of Pediatrics at (610) 402-2540. 
General Medical Staff Meeting 
A meeting of the General Medical Staff will be held on 
Monday, December 10, beginning at 6 p.m., in the Auditorium 
at Lehigh Valley Hospital, Cedar Crest & 1-78, and via 
teleconference in the First Floor Conference Room at Lehigh 
Valley Hospital-Muhlenberg. All members of the Medical Staff 
are encouraged to attend. 
GLVIPA Quarterly General Membership Meeting 
The next quarterly general membership meeting of the Greater 
Lehigh Valley Independent Practice Association will be held on 
Monday, December 17, beginning at 6 p.m., in the Auditorium 
of Lehigh Valley Hospital, Cedar Crest & 1-78. The meeting 
agenda will include the latest updates regarding contract 
negotiations, CAPOE, and a presentation on HIPAA 
compliance. Reminder- in order to receive credit for your 
attendance, please remember to sign in. 
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Who's New 
The Who's New section of Medical Staff Progress Notes 
contains an update of new appointments, address changes, 
resignations, etc. Please remember to update your directory 
and rolodexes with this information. 
Medical Staff 
Appointments 
Michael M. Badellino, MD 
LVPG-Trauma Surgery 
1210 S. Cedar Crest Blvd., Suite 3100 
Allentown, PA 18103-6264 
(610) 402-1350 
Fax: (61 0) 402-1356 
Department of Surgery 
Division of Trauma-Surgical Critical Care/General Surgery 
Site of Privileges - LVH & LVH-M 
Provisional Active 
Sabrina J. Logan, MD 
LVH Pediatric Intensive Care 
Lehigh Valley Hospital 
Cedar Crest & 1-78, P.O. Box 689 
Allentown, PA 18105-1556 
(610) 402-7632 
Fax: (610) 402-7600 
Department of Pediatrics 
Division of Hospital Based Pediatrics 
Section of Critical Care Medicine 
Site of Privileges - LVH & LVH-M 
Provisional Active 
Ali Salim, MD 
LVPG-Trauma Surgery 
1210 S. Cedar Crest Blvd., Suite 3100 
Allentown, PA 18103-6264 
(610) 402-1350 
Fax: (610) 402-1356 
Department of Surgery 
Division of Trauma-Surgical Critical Care/General Surgery 
Site of Privileges - LVH & LVH-M 
Provisional Active 
Anuja Singh, MD 
Primary Care Associates in the LV, PC 
1150 S. Cedar Crest Blvd., Suite 101 
Allentown, PA 18103-7900 
(610) 776-1603 
Fax: (610) 776-6344 
Department of Medicine 
Division of General Internal Medicine 
· Site of Privileges - LVH & LVH-M 
Provisional Active 
Alex T. Thomas, MD 
Base Service Unit 392 
2604 Schoenersville Road 
Bethlehem, PA 18017-3592 
(610) 691-8028 
Fax: (610) 954-0608 
Department of Psychiatry 
Division of Psychiatric Ambulatory Care 
Site of Privileges - LVH & LVH-M 
Provisional Associate 
Appointment to Medical Staff Leadership Positions 
L. Wayne Hess, MD 
Department of Obstetrics and Gynecology 
Position: Chairperson, Department of Obstetrics and 
Gynecology 
Thomas M. McLoughlin, Jr., MD 
Department of Anesthesiology 
Position: Chairperson, Department of Anesthesiology 
Address Changes 
Hamburg Family Practice Center 
700 Hawk Ridge Drive 
P.O. Box488 
Hamburg, PA 19526-9219 
};>- Robert B. Blauser, MD 
};>- David G. Clymer, MD 
};>- Paul J. Chwiecko, MD 
};>- Nicholas A. DiMartino, DO 
};>- E. Brian Petrasek, MD 
Muhlenberg Primary Care, PC 
};>- Jeffrey S. Brown, DO 
};>- Robert L. Stull, DO 
Health Center at Hellertown 
1072 Main Street 
Hellertown, PA 18055-1508 
Thomas R. Lambert, DMD 
2299 Brodhead Road 
Suite E 
Bethlehem, PA 18020-8990 
(610) 868-9928 
Fax: (610) 868-1289 
Status Change 
Suzette V. Barreto, MD 
Department of Medicine 
Division of General Internal Medicine 
From: Associate 
To: Active 
Site of Privileges - LVH & LVH-M 
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Tamar D. Earnest, MD 
Department of Surgery 
Division of General Surgery 
From: Affiliate 
To: Honorary 
Robert G. Madeira, MD 
Department of Medicine 
Division of General Internal Medicine 
From: Limited Duty 
To: Active 
Site of Privileges - LVH & LVH-M 
Douglas C. Wiseman, DO 
Department of Medicine 
Division of Allergy 
From: Affiliate 
To: Associate 
Site of Privileges - LVH-M 
One-Year Leaves of Absence 
David M. Flowers, MD 
Department of Medicine 
Division of Cardiology 
From: Affiliate 
To: Affiliate/LOA 
· Carla M. Rossi, MD 
Department of Medicine 
Division of Infectious Diseases 
From: Provisional Active 
To: Provisional Active/LOA 
Additional One-Year Leave of Absence 
Robert M. Russo, MD 
Department of Family Practice 
Affiliate/LOA 
Resignations 
Jeffrey B. Alpern, DO 
Department of Surgery 
Division of Cardia-Thoracic Surgery 
Richard D. Bellah, MD 
Department of Radiology-Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Larissa Bilaniuk, MD 
Department of Radiology-Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Harry W. Buchanan IV, MD 
Department of Surgery 
Division of Ophthalmology 
Luis I. Campos, MD 
Department of Surgery 
Division of General Surgery 
Rene A. Chapados, MD 
Department of Pediatrics 
Division of Hospital Based Pediatrics 
Section of Critical Care Medicine 
(Effective 1/2/2002) 
Edward C.H. Chen, MD 
Department of Medicine 
Division of Gastroenterology 
William F. Dunleavy, DPM 
Department of Surgery 
Division of Orthopedic Surgery 
Section of Podiatry 
David A. Edmonds, DPM 
Department of Surgery 
Division of Orthopedic Surgery 
Section of Podiatry 
Janet E. Erickson, MD 
Department of Medicine 
Division of General Internal Medicine 
Jerald N. Friedman, MD 
Department of Surgery 
Division of General Surgery 
Richard M. Hughes, MD 
Department of Surgery 
Division of Urology 
Jimmy W. Huh, MD 
Department of Pediatrics 
Division of Hospital Based Pediatrics 
Section of Critical Care Medicine 
Jill V. Hunter, MD 
Department of Radiology-Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Section of Neuroradiology 
William J. Kitei, MD 
Department of Surgery 
Division of Ophthalmology 
Timothy C. Lin, DMD 
Department of Dentistry 
Division of Endodontics 
John K. Mahon, MD 
Department of Medicine 
Division of Neurology 
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Richard I. Markowitz, MD 
Department of Radiology-Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Section of Pediatric Radiology 
Whitney J. McBride, MD 
Department of Surgery 
Division of General Surgery 
Section of Pediatric Surgery 
Sethuraman Muthiah, MD 
Department of Medicine 
Division of General Internal Medicine 
John L. Potter, DMD 
Department of Dentistry 
Division of Periodontics 
Marion B. Rose, MD 
Department of Pediatrics 
Division of Pediatric Subspecialties 
Section of Cardiology 
Eugene M. Saravitz, MD 
Department of Surgery 
Division of Ophthalmology 
Chetan K. Shah, DO 
Department of Medicine 
Division of Nephrology 
Bryan E. Shapiro, MD 
Department of Anesthesiology 
David A. Shields, MD 
Department of Medicine 
Division of General Internal Medicine 
Lisa J. States, MD 
Department of Radiology-Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Section of Pediatric Radiology 
Terrill E. Theman, MD 
Department of Surgery 
Division of Cardio-Thoracic Surgery 
Julio E. Torres, MD 
Department of Medicine 
Division of Hematology-Medical Oncology 
Robert A. Zimmerman, MD 
Department of Radiology-Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Section of Neumradiology 
Allied Health Professionals 
Appointments 
Kristin L Degler, PA 
Physician Extender 
Physician Assistant- PA 
(Lehigh Valley Medical Associates- Edward J. Rosenfeld, MD) 
Site of Privileges - LVH & LVH-M 
Denise E. Emery 
Physician Extender 
Technical- Pacemaker/ICD Technician 
(St. Jude Medical} . 
(Supervising Physician - Steven L. Zelenkofske, DO) 
Stte of Privileges - LVH & LVH-M 
Robert L. Havlicsek II 
Physician Extender 
Technical- Pacemaker/ICC Technician 
(St. Jude Medical} 
(Supervising Physician - Steven L. Zelenkofske, DO) 
Site of Privileges - LVH & LVH-M 
Amy J. Loutrel, PA 
Physician Extender 
Physician Assistant- PA 
(Neurosurgical Associates of LVPG- P. Mark Li, MD) 
Stte of Privileges- LVH & LVH-M 
Eddie W. Malrey, PA·C 
Physician Extender 
Physician Assistant- PA-C 
(Orthopaedic Associates of Allentown- Peter A. Keblish, MD} 
Site of Privileges - LVH & LVH-M 
Sandra L. Malys, RN 
Physician Extender 
Technical- Pacemaker/ICD Technician 
(St. Jude Medical} 
(Supervising Physician - Steven L. Zelenkofske, DO} 
Stte of Privileges - LVH & LVH-M 
Carla B. Peck 
Physician Extender 
Technical- Pacemaker/ICC Technician 
(St. Jude Medical) 
(Supervising Physician - Steven L. Zelenkofske, DO} 
Stte of Privileges - LVH & LVH-M 
Mark A. Sabatino 
Physician Extender 
Technical- Pacemaker/ICD Technician 
(Medtronic lncl) 
(Supervising Physician - Steven L. Zelenkofske, DO) 
Site of Privileges - LVH & LVH-M 
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Change of Supervising Physician 
We've Moved! Brian J. Damweber, PA·C 
Physician Extender 
Physician Assistant- PA-C 
From: Orthopaedic Associates of Allentown - Peter A. Keblish, 
Jr., MD 
On November 1, Breast Health Services at 
LVH-Muhlenberg moved to a new location. 
To: Lehigh Valley Medical Associates- Anthony P. Buonanno, 
Jr., MD 
sne of Privileges - LVH & LVH-M 
Resignations 
John J. Malazia, CRNA 
Physician Extender 
Professional- CRNA 
(Allentown Anesthesia Associates Inc) 
Bradley A. Nace, PA·C 
Physician Extender 
Physician Assistant- PA-C 
(Lehigh Valley Orthopedic Group, PC) 
Robert J. Peterson, PA·C 
Physician Extender 
Physician Assistant- PA-C 
(Orthopaedic Associates of Bethlehem) 
The new address is: 
2597 Schoenersville Road 
Suite 202 
(Medical Office Building closest to 
Westgate Mall) 
New phone number (front desk): 
(484) 884-MAMM (6266) 
New phone number (file room): 
( 484) 884-5419 
New phone number to schedule an 
appointment: (610) 402-2791 
OW 'UJqdiOQ IISBS 
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Tbe entire staff of Medical Staff Serrices 
and Physician Relations wishes you and 
your family a J'ery happy and safe 
hoDday season! 
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MDC Update 
What is MDC? 
The Multidisciplinary Council (MDC) was developed in early 2001 to address systems issues in 
quality improvement that involve multiple LVHHN clinical departments. The council aims to 
develop and implement systems solutions that deliver health care that is: safe, effective, patient-
centered, timely, efficient, and equitable. Quality assurance cases are reviewed for trends, 
multi-department issues, and opportunities for improved communication. 
Council members include: 
~ Karen A. Bretz, MD, Vice Chairperson for Quality Assurance, Department of Anesthesiology 
~ David M. Caccese, MD, Past President, Medical Staff, and Division of General Internal Medicine 
~ Kim Hitchings, Manager, Professional Development 
~ Laurence P. Karper, MD, Vice Chairperson (LVH-M), Department of Psychiatry 
~ Michael W. Kaufmann, MD, Chairperson, Department of Psychiatry 
~ Robert Kricun, MD, Chairperson, Department of Radiology-Diagnostic Medical Imaging 
~ Susan Lawrence, Administrator, Case Management 
~ Pamela F. LeDeaux, MD, Residency Program Director, Department of Family Practice 
~ Zubina M. Mawji, MD, Division of General Internal Medicine 
~ Francine Miranda, Risk Manager, Legal Services 
~ Michael D. Pasquale, MD, Chief, Division of General Surgery and Division of Trauma-Surgical Critical 
Care 
~ Albert J. Peters, DO, Chief, Section of Reproductive Endocrinology & Infertility 
~ David M. Richardson, MD, Department of Emergency Medicine 
~ Howard D. Rosenberg, MD, Co-chief, Section of Pediatric Radiology 
~ Paula L. Stillman, MD, MBA, Senior Medical Director, Care Management 
~ John D. Van Brakle, MD, Chairperson, Department of Pediatrics 
~ Michael S. Weinstock, MD, Chairperson, Department of Emergency Medicine 
From time to time, the MDC will submit updates, evidence-based suggestions, and systems 
changes to Medical Staff Progress Notes. Members of the Medical Staff are invited to relay 
questions about MDC or suggestions for systems issues of concern to the MDC Chairperson via 
email at Zubina.Mawji@lvh.com or via direct page at 610-402-5100 1456. 
MDC Issue #1-Surgical patients with COPD 
Recommendation #1: Order Pre-operative ABGs in selected COPD patients 
Literature review: 
• Post-operative pulmonary complications contributing to morbidity and mortality are at least 
as common as cardiac complications, yet no clear guidelines exist for pre-operative 
pulmonary evaluations. 
• As the surgical incision site approaches the diaphragm, the risk of pulmonary complications 
increases, but is rare following procedures outside the thorax and abdomen. 
• Dyspnea at rest, hypoxemia, and in some studies elevated Pa C02 values, are associated 
with the need for post-operative mechanical ventilation. 
Therefore, pre-operative ABG values may be helpful for those patients with known or suspected 
hypercapnea, and patients hypoxemic on room air, or who require the use of supplemental 
home oxygen. 
Sources: Ann lnt Med 1990; 112: 793-4 
NEJM 1999; 340: 937-44 
NEJM 1999; 341:613-14 
Authors: Karen Bretz, MD 
Stephen Matchett, MD 
David Caccese, MD 
The Last Word ... 
Tips and Techniques for the Lastword"' User 
December, 2001 -Volume 1, Issue 2 
IN BOX Alerts & Reminders 
by Carolyn K. Suess, R.N. 
The INBOX- Alerts & Reminders 
window on the Physician Base screen in 
Lastword serves as a reminder to review 
abnormal lab results, as well as new 
ancillary results. The alerts are provided 
as a courtesy to physicians practicing at 
Lehigh Valley Hospital. 
Abnormal Lab Results 
To access abnormal lab results, click on 
this alert, then click on the Select button 
located at the bottom of the INBOX -
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New Imaging/ Ancillary 
and Abnormal Lab 
Results 
Figure 1 - Physician Base Screen 
also double-click on the alert to open it -
see Figure 1 ). The lnbox: Resolve Lab 
Results screen opens, displaying 
abnormal results (see Figure 2). 
The window on the left side of the 
screen lists the patient's name, the name 
of the test, and abnormal and FYI 
indicators (see heading FYI and Primary 
Alerts). Click on the patient then, click 
on the Select button at the bottom of the 
window to choose the result you wish to 
view (you may also double-click to 
select the patient). Upon selecting the 
patient, the Result Text window displays 
the abnormal result information. Click 
Page 15 
on the Acknowledge button to indicate 
you have viewed the result. 
To forward the result to another 
provider, click on the Forward to ••• 
button. The Forward Alert window 
opens (see Figure 3). Right click on the 
Forward to: text box to view a provider 
list. You may also free text the provider 
name by entering last name followed by 
a comma and full first name. The result 
may be forwarded to a total of four 
providers. 
If you wish to include a reason for 
forwarding the result, click on the Enter 
Editor button and free text a message in 
the Reason for Forward window. 
Adding a reason for forwarding a result 
is strictly When you have 
Figure 2 - lnbox: Resolve Lab Results window 
completed your message, click on the 
Navigate pull-down menu and select 
OK. 
To reassign the abnormal lab result to 
another provider for sign-off, click on 
the pull-down list next to the Reason for 
Reassign text box and make a selection 
(you may also free text your reason in 
the text box). Click on the Reassign 
button and the alert will be reassigned to 
the provider you listed in the Forward 
to: text box. 
Click on the Forward on Record button 
to create a record of the forward 
transaction. If you prefer not to have a 
record of the transaction, click on the 
Forward off Record button. 
Result Rbnl 1D111al Range Unl ts 
S.3 l 12-U 1/dl 






Should you decide you do not want to 
forward the result, click on the Cancel 
button to return to the lnbox: Resolve 
Lab Results screen. 
New Imaging Results 
Accessing new imaging results is done 
in much the same way as accessing 
abnormal lab results. Click on the New 
imaging/ANC results ... alert, then click 
on the Select button located at the 
bottom of the INBOX window (you may 
also double-click on the alert to select 
it). The lnbox: Resolve 
Ancillary/Radiology Results screen 
opens, displaying new results. 
The left side of the screen lists the 
patient's name, the name of the test, and 
FYI indicators (see heading FYI and 
Figure 3 - Forward Alert window 
3 
Primary Alerts). Click on the patient 
then click on the Select button at the 
bottom of the window to choose the 
result you wish to view (you may also 
double-click on the patient to select it). 
Upon your selection, the Result Text 
window displays the ancillary/radiology 
result infonnation for the patient. Click 
on the Acknowledge button to indicate 
you have viewed the result. This 
removes the entry from your list. 
As with abnormal lab results, the same 
steps are used to forward imaging results 
to other providers. 
It is important to note, acknowledging an 
INBOX result is not the same as 
verifying and signing them in the 
IMNET /PIM medical records system. 
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FYI and Primary Alerts 
As mentioned in the previous 
paragraphs, FYI indicators may appear 
in either the lnbox: Resolve Lab Results 
or the lnbox: Resolve 
Ancillary/Radiology Results screens (see 
Figure 2). FYI alerts are those that had 
been ordered by another physician in 
your group. These alerts are sent to your 
INBOX as a courtesy. 
Primary alerts are those that are 
associated with the ordering physician. 
That is to say, any lab or ancillary result 
you order generates a primary alert. 
Starting in mid-December of this year all 
FYI alerts will automatically purge from 
your INBOX after five days, and all 
primary alerts will automatically purge 
after 1 0 days. This does not mean the 
results are purged. Lab results can be 
displayed in the Viewer and Laball chart 
tabs, and imaging results can be 
displayed in Anc Results chart tab. 
4 
To learn more about INBOX and other 
Lastword features, please take a moment 
and review the on-line documentation -
for Lastword Version 4.1. 7. Both the 
CAPOE and Non-CAPOE Physician 
User Guides can be found on the 
L VHNN Intranet under the Resources 
heading Lastword for Physicians. 
If you wish to obtain a paper copy of 
either document, please contact one of 
the Physician Software Educators on 
staff: 
Lynn Corcoran-Stamm - ext.142S 
Kimberlee Szep, R.N. - ext. 1431 
Carolyn K.. Suess, R.N. - ext.1416 
Lynn, Kimberlee and Carolyn will be 
pleased to assist you. 
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ARTERIAL BLOOD GASES 
LABORATORIES Page 19 
LAB-LINK 
Information And Advice About Our Laboratory 
NoveDJ.ber 15, 2001 
Effective Decem.ber 4, 2001, at 10:00 a.m., Arterial Blood Gas testing at 
Lehigh V ailey Hospital-Muhlenberg will be transferred from Respiratory 
Services to Health Network Laboratories Rapid Response lab. Collection procedures 
will continue to be maintained by the respiratory staff. 
As with laboratory reports at all Lehigh Valley Hospital sites, results will be sent from 
the laboratory computer system directly to Phamis terminals. 
The following parameters will be phoned by the laboratory: 
};;>- Critical Values 
pH: <7.20 or >7.55 
pC02: <20mmHg or >60mEq/L 
p02: <60mmHg 
TC02: < 15mEq/L or >40mEq/L 
};;>- All specimens originating from the Operating Room 
};;>- When requested by the ordering physician 
Changes in the Phamis system are being defined by Information Services and 
educational inservices will be conducted by nurse educators for their respective staff. 
Note: To provide standardized reporting at ail hospital sties, the 
TC02 param.eter will be added to the ABG battery at ·Cedar Crest and 
17th Street sites. 
Ifyou have any questions, please call Dolores Benner at 610-402-8177, Dr. Elizabeth 
Dellers at 484-884-4267, or Dr. William Dupree at 610-402-8140. 
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Health Network CHEMISTRY 
LABORATORIES 
LAB-LINK 
Information And Advice About Our Laboratory 
Nove~ber15,2001 
When testing for Beta Human Chorionic Gonadotropin (BhCG), a spuriously 
elevated result may be obtained' in those individuals with the presence of 
heterophil antibodies. 
Therefore, effective Dece~nber 3, 2001, the following comment will be 
attached to all BhCG results: 
'"~ spuriously elevated BhCG result ntay be obtained 
in the presence of heterophil antibodies. Before 
ntaking a final diagnosis based on an elevated or 
repetitively inconclusive BhCG result, an additional 
BhCG test - with the use of heterophilic antibody 
blocking ntechanism (not FDA approved) - ntay be 
indicated. 
The test ntust be ordered by a physician as: 
"Beta hCG with heterophilic antibody blocking 
ntechaniSnt" (Test Code BhCGH)." 
NOTE: This test is not replacing the basic pregnancy test (Beta Human 
Chorionic Gonadotropin, BhCG). It is to be utilized as a follow-up test 
when the initial results do not correlate with the clinical picture. 
If you have any questions, please call our Customer Care Call Center at 
610-402-8170 or Dolores Benner at 610-402-8177. 
lEHJeHVAILEY 
HOSPITAL 
THERAPEUTICS AT A GLANCE 
The following actions were taken at the October 2001 Therapeutics Committee Meeting -Joseph Ottinger, R.Ph., MS, MBA, 
Janine Barnaby, R.Ph., Jenny Boucher, Pharm.D., Viraj Patel, Pharm.D., Heidi Mayville, Pharm.D. 
COMPAZINEAUTOSUB 
The Therapeutics committee approved a therapeutic substitution to address an on-going product shortage 
ofprochlorperazine injection. The Pharmacy was authorized to change all 'prn' prochlorperazine 
injection orders to promethazine injection. The following dose conversion was endorsed: 
prochlorperazine doses of Smg or less will be converted to 12.5 mg of promethazine 
prochlorperazine doses > than Smg but ~ 1 Omg will be converted to 2Smg of promethazine. 
The initial route and frequency of administration will be preserved in the conversion process, as will any 
limits on the number of doses or duration of therapy specified in the original order. 
FORMULARY ADDITIONS 
The Therapeutics committee approved the following agents to the Formulary at its October meeting: 
Hydrocodonelacetaminophen tablets- Vicodin and Vicodin ES formulations 
Dorzolamide/timolol ophth soln- CoSopt ophth soln 
Fluticasone/salmeterol diskus inh- Advair Diskus inh 
Oxcarbazepine tablet-Trileptal 
Levetiracetam tablet- Keppra 
Glargine insulin- Lantus insulin 
HEPARIN THERAPEUTIC RANGE CHANGES 
The annual recalibration of the therapeutic heparin range has been performed by the Clinical Laboratory. 
This activity is necessitated by a change in the lot number of the existing reagent. Usually the titration 
curve is modified by a small degree- unlike our previous year's adjustment, that was the result of a the 
purchase of a new high sensitivity reagent. The new therapeutic target, coincident with a heparin activity 
level of 0.3 units/ml-0. 7 units/ml, is 69-101 seconds. ALL heparin regimens previously identified on 
preprinted order sheets will be adjusted accordingly. Attached to this newsletter is the template for the 
revised Heparin Order Sheet, based on the modified therapeutic range. 
DROTRECOGIN ALFA 
A unique 'physician order form' was approved that combined a criteria for use section along with the 
medication order for this novel agent. Although not yet FDA approved, this agent appears to have 
provided a significant mortality benefit in a limited study population. Therefore, the intent of the new 
document was to provide the clinician with a clearly identified set of criteria (established in the 
PROWESS study), where this agent was found to be beneficial. This extraordinary step was motivated 
not only by the unique mechanism of action of this product, but also by its forecasted financial impact. 
Although, not known at this time, the cost of a course of treatment with this agent may range from 
$5,000-$20,000 per patient. A limitation on perspective prescribers and usage in selected patient-care 
areas was also approved. 
Attached is the template for this document, which was formulated through the combined efforts of Leslie 
Baga, (Trauma Study Coordinator), Dr. Mark Cipolle, Dr. Marcelo Gareca, Dr. Stephen Matchett and Joe 
Ottinger (Clinical Pharmacy). 
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PROTOCOL ORDER SIIBBT :FOR Drotrecogin Alfa IXIGRI§I'M) IR SEVERE SEPSIS 
RESTRICI'ED TO PHYSICIAN SPECIALITIES PRACTICING IN TilE ICU INCLUDING: 
PULMONARY SPECIALISTS, INFECI'IOUS DISEASE SPECIALISTS, AND SURGEONS 
CRITERIA SHEET MUST BE COMPLETED AND SENT TO PHARMACY PRIOR TO DISPENSING DRUG 
PA'l'IEKT MUST SATJSFY ALL CRITERIA TO RECEIVE DROTECOGIN ALFA 
YES J.II'O 
KJunm or napected iDfection {e.c., positive blood culture, perforated vtacaa, WBC co111lt 
in normally sterile body flaicl, radiosraphlc evidence of pneumonia with the production 
of t nutum.l 
YES J.II'O 
!Fever ;;;o; 38 depeea C (100.4 dep-eu F) or hypothermia s 36 dep-eu C (96.8 dep-eu F) 
~ C!:: 90 beats/minute except in those patients with a medical conclltion lmo'Wil to increase 
the heart rate 
nc co1111t ;;;o; 12,000/mm• or s 4,000/mm• or > 10% Immature neutropldla 
~aplratozy rate :?! 20 breaths per minute or a PaC02 s 32mm Be or the aac of mecballical 
"ntUation for an acute process 
AND 
ORGAN DYSFUJ.II'CTIOJI W1'1'BDI 48 HOURS DUB TO SBPSIS DESPITE ADEQUATE FLUID RESUSCITATIOJI 
(One of the following) 
CRITBRL\ 
YES J.II'O Ol'ftll tion 
11· CUcllovucular 
All arterial aytoUc BP s 90 mm Be OR a MAP s?Omm Be for at least 1 hour despite 
adequate flaicl reaaacttation, adequate intravascular wlume atataa and/or the need for 
vuopreuoza to maintain ayatoltc blood pre8II1II'C :?! 90 mm Be or MAP :?! 70 mm Be· 
2 Renal 
Urine o'llt1nlt < 0.5 ml/b./br for > 1hour. deaDite adeauate fluid reaaacitation 
3 Resptratozy 
Pa02/Fl02 ratio s 250 in the presence of other dyaflmctlonal orpu. (If patient baa 
Dlleumo:aia alone the D&tient maat have a Pa02/Fi02 ratio s 200l 
14 BematolocJ' 
Platelet co1111t of< 80,000/ mm• or a 60% decrease in the platelet co111lt from the bJchut 
lnlue recorded over the DUt 3 daya. 
~ lletaboltc Actdoata 
PBs 7.30 or base deftctt ;;;o; 5.0 mEq/L or a pluma lactate level> 1.5 times the upper Umtt 
IDf llOrmal. 
AND NONE OF THE FOLLOWING 
or the followiac Contrabldlcatlona: 
-Yes_ No_ Active internal bleeding 
-Yes_ No_ Recent (within 3 months) hemorrhagic stroke 
-Yes_ No_ Recent (within 2 months) intracranial or intraspinal surgery, or severe 
head trauma requiring hospitalization 
-Yes_ No_ Any history of intracerebral arteriovenous malformation, cerebral 
aneurysm, or mass lesion of the CNS 
-Yes_ No_ Less than 12 hours post surgery requiring general or spinal anesthesia 
-Yes_ No_ Trauma patients with increased risk of life-threatening bleeding 
-Yes_ No_ Patients with an epidural catheter 
-Yes_ No_ Patients with known hypersensitivity to drotrecogin alfa (activated) or 
any component of the product 
-Yes_ No_ Patients who have via Advanced Directives indicated that therapy of 
this type not be pursued. 
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Other patient specific Issues THAT MAY PRECLUDE USE OF TinS AGENT, BUT THAT ARE LEFT TO 
THE DISGRESSION OF THE PRESCRIBING PHYSICIAN INCLUDE: 
-Initial platelet count< 20,000/mm3 
-History of congenital bleecting diatheses 
-GI bleeding within 6 weeks 
-Less than 3 months from ischemic stroke 
-Chronic renal failure requiring dialysis 
-Known or suspected portosystemic hypertension, chronic jaundice, cirrhosis, or chronic ascites 
-Unfractionated. heparin within the last 8 hours (<15,000 units per 24 hours permitted) 
-Concurrent use of a direct thrombin inhibitor 
-Use of 'Treatment dose' Low Molecular Weight Heparins (LMWH) wtmn the past 12 hours. 
-ASA (>650 mgf day within the past 3 days) or NSAIDS should be discontinued 
-Anti-platelet agents, thrombolytics (Within the past 3 days), or glycoprotein IIbflDa inhtbitor (within the past 7 days) 
-Pregnancy and/or active breast feeding 
-Known hypercoaguable condition 
-Recent histmy of bone marrow or solid organ transplantaton. 
-Patients with HIV (CD4 <SO) 




Start Drotecogin alfa 24 meg/kg/hr. (patient wgt. kg; no dosing guidelines exist for pateints > 135 kg)) ASAP. Infuse at this rate for 
96 hours. If therapy is interrupted, drotrecogin should be discontinued 97 hours after therapy was initially started 
Drotrecogin should be administered via a dedicated line. 
Hold all other anticoagulant agents .. 
Hold infusion and contact physician immediately, if arry bleeding is noted 
Hold infusion 1 hour prior to arry percutaneous procedure or major surgery. 
Resume infusion 1 hour qfter a percutaneous procedure and 12 hours after major surgery, unless otherwise instructed 
Monitor: 
CDC daily, while on drotrecogin. 
PATIENT MEETS AU. PROTOCOL CRITERIA DESCRIBED ABOVE.. INITIATE THERAPY DECSCRIBED ABOVE: 
Physician Signature: __________ _ Date: __________________________ _ 
DRUG ALLERGIES: REACTIONS: 
laboratory 
Normal= 21-37 seconds 
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Equivalent therapeutic aPTI range for 0.3-0.7 units/m.l heparin level (based on anti-factor Xa 




2. Use "Cardiae" dosing protocol (ACC/ AHA Modei)..See reverse side f![ order. 
Use Modified Raschke dosing protocol CPEIDVD-See reverse side f![ order. 
Use Stroke/TIA dosing protocoL See~ side f![ order. 
Use specific dosing regimen identified below !MJ!n describe heparin dose modifications and P'IT targets 
ACC/AHA <Cardiac~ Loading dose of 60 units/kg (maximum bolus 4.000 units). followed,hy.!!!! initial infusion rate of 12 
ypits/kg/br (maximum 1.000 units/hr. Adjust as indicated below. 
Cardiac~ protocol adjustments 
P1T <38 Give 40 unit/kg bolus (maximum 4,000 units):increase heparin infusion rate by 
100 unitslhr (<80kg) OR 
200 unitslhr (~80kg) 
P1T 38-55 Give 20 unit/kg bolus; increase heparin infusion rate by 
100 unitslhr {all weights) 
P1T 56-68 Increase heparin infusion by 
100 unitslhr {all weights) 
P1T 69-89 No CHANGE 
PIT 90-119 Decrease heparin infusion rate by 
100 unitslhr (all weights) 
P1T 120-145 Decrease heparin infusion rate by 
100 unitslhr (<80kg) OR 
200 unitslhr (~80kg) 
P1T 146-180 Stop heparin for 1 hour. Decrease heparin infusion rate by 
200 unitslhr (<80kg) 
300 unitslhr (~80kg) 
PTI > 180 ~PHYSICIAN FOR FUR TilER ORDERS 
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Raschke CDVT/PE protocol) Loading dose of 80 units/kg, followed~ m1 initial infusion rate of ll units/kg/hr. Adjust A§ indicated 
below. 
Modified Raschke .!!mmrin protocol adjustments <PEIDVD 
P1T < 38 80 unit/kg bolus. Increase infusion rate by 
4 unitslkglhr 
P1T 38-68 40 units/kg bolus. Increase infusion rate by 
2 unitslkg!hr 
P1T69-101 NOCHANGE 
P1T 102-130 Reduce infusion rate by 1 unitslkg!hr 
P1T 131-155 Reduce infusion rate by 2 unitslkglhr 
P1T 156-179 Hold heparin for one hour. Reduce infusion rate by 3 units/kg/hr. 
P'm180 CALL PHYSICIAN FOR FURnmR ORDERS. 
Stroke/TIA protocol Loading dose not recommended. Initiate infusion rate at 15 units/kg/hr. Adjust as indicated 
below 
Stroke/11A heparin protocol adjustments 
P1T < 55 Increase infusion rate by 100 unitslhr 
PIT 55-100 NO CHANGE 
P1T 101-140 Decrease infusion rate by 100 unitslhr 
PTI> 140 Hold he arin for 2 hours. Reduce infusion rate b 200 unitslhr 
RENAL TRANSPLANT DRUGS -DRUG INTERACTIONS 
Many patients who have undergone transplantation take more than 8 different 
medications daily as part of their required therapy. Renal transplant recipients are 
prescribed multiple medications to sustain the transplanted organ and to treat concomitant 
conditions; therefore, encountering a drug-related problem is common in this patient 
population. The purpose of this article is to identify drug-related problems, specifically 
interactions involving drugs commonly used in renal transplant patients. Drug 
interactions, a common type of drug-related problem, are categorized as pharmacokinetic, 
pharmacodynamic, or a combination of both. Pharmacokinetic drug interactions include 
changes in absorption, distribution, excretion, and metabolism, whereas 
pharmacodynamic drug interactions may lead to antagonistic or synergistic effects. Not 
all drug interactions are undesirable; in fact, many drug interactions are used to produce 
desirable effects (e.g, using a calcium channel antagonist to increase immunosuppressant 
concentrations, thereby requiring a lower immunosuppressant dose). 
Patients who take a drug that has a narrow therapeutic index with another drug( s) that 
interferes with the pharmacokinetic properties of the object drug are at increased risk of 
experiencing a drug interaction. Also, patients who take multiple medications daily or 
take multiple doses of medications daily are at an increased risk for an undesirable drug 
interaction. Because renal transplant patients often take immunosuppressive agents that 
have narrow therapeutic indices and are subjected to multiple medications daily, these 
patients are vulnerable to experiencing adverse drug events. To prevent adverse drug 
interactions, an alternative therapy should be considered when possible or the dose or 
schedule of the drugs should be adjusted to reduce the occurrence of an adverse effect. 
Careful monitoring to prevent and detect adverse effects is an essential part of patient 
care. 
Pharmacokinetic Drug Interactions 
A common pharmacokinetic interaction involves drugs that interfere with the absorption 
of other medications. Drugs that bind (e.g, cholestyramine) potentially increase the 
gastrointestinal absorption of another drug (e.g, tacrolimus). Typically administering the 
agents 2-3 hours apart can prevent this interaction. Prokinetic agents 
(e.g,metoclopramide) interfere with the rate of absorption. Since many transplant 
patients take prokinetic agents, this may increase the bioavailability of other 
medications. This is of clinical significance with immunosuppressive agents, such as 
cyclosporine. If the prokinetic agent cannot be avoided, careful monitoring (e.g, 
serum drug levels, clinical presentation of patient) and adjustments should be made to 
prevent immunosuppressant toxicity. 
CYP-450 Inhibition 
Cyclosporine and tacrolimus are two of the most commonly used immunosuppressants in 
renal transplant patients. Both cyclosporine and tacrolimus are metabolized 
by the 3A-4 subfamily of the cytochrome P450 (CYP-450) system. This system is 
responsible for the metabolism of more than 30% of drugs, and therefore many 
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medications that induce or inhibit the CYP-450 system are commonly administered and 
may potentially cause a drug interaction. Examples of classes that inhibit the 
CYP-450 system include azole antifungals, macrolide antibiotics, and calcium channel 
antagonists. Examples of drugs that induce the CYP-450 system include phenytoin and 
rifampin. Although it is difficult to predict the onset of the interaction on an individual 
basis, the time to onset is related to the half-life of the drugs involved and the half-life of 
enzyme production. Significant drug interactions of this type have been known to cause 
nephrotoxicity, neurotoxicity, and graft rejection. 
HMG-CoA Reductase Inhibitors 
Many transplant patients have hyperlipidemia and are frequently prescribed HMG-CoA 
reductase inhibitors. Cyclosporine, tacrolimus, and sirolimus may interact with HMG-
CoA reductase inhibitors, which could result in increased serum concentrations ofHMG-
CoA reductase inhibitors up to 20-fold. This interaction can result in serious injury by 
causing rhabdomyolysis, acute renal failure, and even graft loss. It is recommended when 
using these agents in combination with cyclosporine, tacrolimus, or sirolimus to begin 
therapy with a low-dose HMG-CoA reductase inhibitor and to obtain baseline and follow-
up creatinine phosphokinase measurements every 6 months. 
P}larmacodynamic Drug Interactions 
There.are numerous pharmacodynamic interactions associated with immunosuppressive 
drug therapy. The concomitant use of cyclosporine or tacrolimus with aminoglycosides, 
vancomycin, amphotericin B, ganciclovir, acyclovir, and nonsteroidal anti-inflammatory 
medications may increase nephrotoxicity. Gingival hyperplasia is another adverse effect 
associated with agents commonly used in transplant patients, such as cyclosporine, 
phenytoin, and calcium channel antagonists. Other adverse drug effects seen in this 
population include hyperkalemia caused by ACE inhibitors, potassium-sparing diuretics, 
and cyclosporine or tacrolimus; and excessive hair growth as a result of minoxidil and 
cyclosporine. Myelosuppression can result from administration of agents commonly 
prescribed in the transplant population. Drugs such as ganciclovir, trimethoprim-
sulfam.ethoxazole, mycophenolate, allopurinol, and azathioprine can cause 
myelosuppression. To avoid adverse events, selection of another drug in a different class 
should be considered. However, in many situations, avoiding a medication is not 
possible, and it may be necessary to use more than 1 medication associated with a 
particular adverse event (e.g, gingival hyperplasia associated with the concomitant use of 
phenytoin and cyclosporine ). In these instances, careful attention to monitoring ( e g, 
adequate dental hygiene, electrolyte measurements, and complete blood count 
monitoring) is necessary. Refer to Tables 1, 2, and 3 for lists of common drug 
interactions with immunosuppressive agents. 
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TABLE 1: Cyclosporine (CsA) and Tacrolimus Drug Interactions 
DRUG MECHANISM EFFECTS COMMENTS 
Acetazolamide Decreases clearance Increases Cs/FK level Monitor levels 
Acyclovir Crystallization in renal Nephrotoxicity Make sure patient is 
tubules adequately hydrated; 
monitor SCr and renal 
function; infuse slowly 
Amikacin Synergistic Nphrotoxicity Monitor levels; Monitor 
nephrotoxicity Scr and renal function 
Amiloride Decreases K + secretion Hyperkalemia A void in transplant 
recipients 
Amiodarone Decreases clearance Nephrotoxicity Monitor SCr and renal 
funct 
Amlodipine Decreases clearance Increases CsA/FK level 10% to 15% increase in 
CsAIFK level; monitor 
levels 
Amphotericin B Synergistic Nephrotoxicity Make sure patient is 
nephrotoxicity adequately hydrated and 
monitor electrolytes 
Atorvastatin Decreases clearance of Myopathy, Monitor CPK and for 
statins rhabdom yo lysis the development of 
rhabdomyolysis 
Azithromycin Decreases clearance Increases CsAIFK level Monitor levels 
Bromocriptine Decreases clearance Increases CsAIFK level Monitor levels 
Calcium channel Synergistic gingival Gingival hyperplasia Adequate dental 
antagonists hyperplasia hygiene 
Carbamazepine Increases clearance Decreases CsAIFK level Monitor levels 
Carvedilol Decreases clearance Increases CsAIFK level Moriitor levels 
Chloroquine Decreases clearance Increases CsAIFK level Monitor levels 
Cholestyramine Decreases absorption Decreases CsAIFK level Separate doses by 3 
hours 
Cimetidine Decreases clearance Increases CsA/FK level Use another H2 
antagonist agent 
(ranitidine, famotidine 
Clarithromycin Decreases clea.Jllllce Increases CsAIFK level Monitor levels 
Clotrimazole Decreases clearance Increases CsAIFK level Monitor levels 
Colchicine Increases neurotoxicity Gastrointestinal 
dysfunction and 
neuromyopathy 
Co-trimoxazole Inhibits creatinine Increases serum Monitor SCr and renal 
secretion creatinine function 
Danazol Inhibits clearance Increases CsAIFK level Monitor levels 
Digoxin Decreases clearance of Increases digoxin level Monitor digoxin level 
digoxin 
Diltiazem Decreases clearance Increases CsA/FK level Monitor levels 
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Enalapril Renal dysfunction Increases serum Monitor SCr and renal 
creatinine function 
Erythromycin Decreases clearance Increases CsA/FK level Monitor levels 
Fluconazole Decreases clearance Increases Cs:AJFK level Monitor levels 
Fluvoxamine Decreases clearance Increases CsA/FK level Monitor levels 
Fosinopril Renal dysfunction Nephrotoxicity Monitor SCr and 
renal function 
Fosphenytoin Increases clearance Decreases CsA/FK level Monitor levels 
Ganciclovir Synergistic Nephrotoxicity Make sure patient is 
nephrotoxicity adequately hydrated; 
monitor SCr and renal 
function 
Gentamicin Synergistic nephrotoxi Nephrotoxicity Monitor levels; monitor 
SCr and renal function 
Grapefruit juice Increases bioavailability Increases CsA/FK level Monitor levels 
Griseofulvin Decreases CsAIFK level Decreases CsA/FK 
effectiveness 
Isoniazid Decreases clearance Increases CsA/FK level Monitor levels 
Itraconazole Decreases clearance Increases CsAJFK level Monitor levels; decrease 
dosage SO% to 85% 
Ketoconazole Decreases clearance Increases CsA/FK level Monitor levels; decrease 
dosage 25% to 75% 
Lovastatin Decreases clearance of Myopathy, Monitor CPK and for 
statins rhabdom yo lysis the development of 
rhabdomyolysis 
Methylprednisolone Decreases clearance Increases CsAJFK level Seen at high doses of 
methylprednisolone 
Methyltestosterone Decreases cyclosporine Increases CsA/FK level Monitor levels 
metabolism 
Metoclopramide Decreases gastric Increases CsA/FK level Increase peak and AUC 
emptying time by 25% to SO%; 
monitor levels 
Metronidazole Decreases clearance Increases CsA/FK level Monitor levels 
Nafcillin Increases CsAIFK Decreases CsA/FK level Monitor levels 
clearance 
Nefazodone Decreases CsAIFK Increases CsA/FK level Monitor levels 
clearance 
Nicardipine Decreases CsAIFK Increases CsAJFK level Monitor levels 
clearance 
NSAIDs Synergistic Nephrotoxicity CsAJFK induced 
nephrotoxicity vasoconstriction is 
influenced by 
prostaglandin inhibition; 
monitor SCr and renal 
function 
Octreotide Decreases intestinal Decreases CsA!FK level Monitor levels 
absorption of CsAIFK 
Phenobarbital Increases CsAIFK Decreases CsA/FK level Monitor levels 
clearance 
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Phenytoin Synergistic gingival Gingival hyperplasia Adequate dental 
hyperplasia hygiene 
Pravastatin Decreases clearance of Myopathy, Monitor CPK and for. 
statins rhabdom yo lysis the development of 
rhabdomyolysis 
Rifabutin Increases CsAIFX Decreases CsAIFK level Monitor levels; rifabutin 
clearance is a less potent hepatic 
enzyme inducer than 
rifampin 
Rifampin Increases CsAIFX Decreases CsA/FK level Monitor levels 
clearance 
Simvastatin Decreases clearance of Myopathy, Monitor CPK and for 
statins rhabdomyolysis the development of 
rhabdomyolysis 
Sirolimus Increases CsA levels Monitor levels; monitor 
SCr and renal function 
Spironolacton Decreases K + secretion Hyperkalemia MonitorK+ 
Terbinafine Decreases CsA/FK Increases CsA/FK level Monitor levels 
clearance 
Ticlopidine Increases CsA/FK Decreases CsA/FK level Monitor levels 
clearance 
Tretinoin Inhibits tretinoin Increases tretinoin 
metabolism toxicity 
Triamterene Decreases K + secretion Hyperkalemia MonitorK+ 
Tobramycin Synergistic Nephrotoxicity Monitor levels; monitor 
nephrotoxicity SCr and renal function 
Vaccines Decreases response to 
vaccination 
Valacyclovir Hemolytic uremic Renal dysfunction Monitor SCr and renal 
syndrome function 
V alproic acid Decreases clearance Increases CsAIFK levels Monitor levels 
Vancomycin Synergistic Nephrotoxicity Monitor SCr and renal 
nephrotoxicity function 
Verapamil Inhibit CsAIFK Increases CsA/FK levels Monitor levels 
clearance 
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TABLE 2. Sirolimus Drug Interactions 
DRUG MEcHANISM EFFECTS CO:MMENTS 
Amiodarone Decreases clearance Increases sirolimus 
levels 
Atorvastatin With sirolimus and Rhabdomyolysis Monitor CPK and for 
cyclosporine development of 
rhabdomyolysis 
Azithromycin Decreases clearance Increases sirolimus 
levels 
Carbamazepine Increases clearance Decreases sirolimus 
levels 
Cimetidine Decreases clearance Increases sirolimus 
levels 
Clarithromycin Decreases clearance Increases sirolimus 
levels 
Clotrimazole Decreases clearance Increases sirolimus 
levels 
Cyclosporine Decreases clearance Increases sirolimus and 
cyclosporine levels 
Danazol Decreases clearance Increases sirolimus 
levels 
Diltiazem Decreases clearance Increases sirolimus 
levels 
Erythromycin Decreases clearance Increases sirolimus 
levels 
Fluconazole Decreases clearance Increases sirolimus 
levels 
Fluvastatin Rhabdomyolysis* Monitor CPK and for 
(shown with development of 
coadministration with rhabdomyolysis 
sirolimus and 
cyclosporine) 
Fluvoxamine Decreases clearance Increasessirolimus 
levels 
Grapefruit juice Increases bioavailability Increases sirolimus 
levels 
Griseofulvin Increases clearance Decreases sirolimus 
levels 
Indinavir Decreases clearance Increases sirolimus 
levels 
Isoniazid Decreases clearance Increases sirolimus 
levels 
Itraconazole Decreases clearance Increases sirolimus 
levels 
Ketoconazole Decreases clearance Increases sirolimus 
levels 
Lovastatin Rhabdomyolysis* Monitor CPK and for 
(shown with development of 




Metronidazole Decreases clearance Increases sirolimus 
levels 
Nafcillin Increases clearance Decrea5es sirolimus 
levels 
Nefazodone Decreases clearance Increases sirolimus 
levels 
Phenobarbital Increases clearance Decreases sirolimus 
levels 
Phenytoin Increases clearance Decreases sirolimus 
levels 
Pravastatin Rhabdomyolysis* Monitor CPK and for 
(shown with development of 
coadministration with rhabdom yo lysis 
sirolimus and 
cyclosporine) 
Rifabutin Increases clearance Decreases sirolimus 
levels 
Rifampin Increases clearance Decreases sirolimus 
levels 
Ritonavir Decreases clearance Increases sirolimus 
levels 
Saquinavir Decreases clearance Increases sirolimus 
Sertraline Decreases clearance Increases sirolimus 
levels 
Simvastatin Rhabdom yo lysis* Monitor CPK and for 
(shown with development of 
coadministration with rhabdomyolysis 
sirolimus and 
cyclosporine) 
Vaccines Decrease response to 
vaccination 
V alproic acid Decreases clearance Increases sirolimus 
levels 
Verapamil Decreases clearance Increases sirolimus 
levels 
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TABLE 3. Azathioprine and Mycophenolate Mofetil (MMF) Drug Interactions 
DRUG MECHANISM EFFECTS COMMENTS 
ACE inhibitors Synergistic Anemia, neutropenia Increase bone marrow 
myelosuppression toxicity; monitor CBC 
Acyclovir Competition for tubular Increases toxicity Anemia, neutropenia 
secretions 
Allopurinol Inhibits xanthine Severe neutropenia Decrease azathioprine 
oxidase dose by 75%; monitor 
CBC 
Cholestyramine Decreases absorption of Do not administer 
MMF together; increase bone 
marrow toxicity; 
monitor 
Ganciclovir Synergistic Anemia, neutropenia MonitorCBC 
myelosuppression 
Probenecid Inhibition of tubular Increase levels 
secretions 
Salicylates Increase free fraction of Increase toxicity Usually seen at high 
mycophenolate doses of salicylates 
TMP/SMX 
TMP/SMX Synergistic Anemia, neutropenia MonitorCBC 
myelosuppression 
Transfusion Related Acute Lung Injury 
(You are encouraged to copy and distribute this letter) 
Department of Health and Human Services 
Public Hearth Service 
Food and Drug Administration 
1401 Rockville Pike 
RockVille, MD 20652·1448 
August 13,2001 
Dear Colleague: 
This is to alert you tc the possibility that patients whc receive blood products, particular1y plasma-
containing products, may be at risk for Transfusion Related Acute lung Injury (fRAU), a serious 
puJmcnary syndrome that can lead to death if not recognized and treatecl appropriately. Even small 
amounts of plasma in packed red blood cells may induce TRA.U. R~niticn of symptoms and 
immediate treatment are imperative. 
Reports 
The first TRALI fatality was reported to the Center for Biologics Evaluation and Research {CBER) in 
1992. Since then, CBER has received more than 45 fatality reports af TRALI. As of FY2000 this 
represented 13 percent of all transfusion fatafities. TRAI..I is thought to be the third leading cause of 
transfusion related death. The majority of deaths were associated with fresh frozen plasma 
transfusions; fewer were caused ey packed red blood cell tra'1sfusions and platelet transfusion&. In 
mast cases, follaw..up donor antibody screens implicated donors who were multiparous females and 
were positive for anti-t-!LA or anti-granulOCyte antibodies. Non-fatal TRAU events reported by licensed 
blood estabfiShments through Med Watch or as Biological Product Deviation reports are also on the 
inaease. There have been 26 such reports since 1999. This finding may be attnbutable to better 
recognition and reporting of events. Because af misdiagnosis andJor underreoorting, the full scope of 
TRALI is not known. · 
Description and Cause of Problem 
TRAL.I is a well-characterized clinical constellation of syml)toms including dyspnea, hypoten$iCn. and 
fever. The radiological picture is of bilateral pulmonary infiltrates Wltl'lout evidence of cardiac 
compromise or fluid overload. Symptoms tyl)ieally begin 1·2 hours after transfusion and are fully 
manifest within 1 ..e hours. Products typically implicated in TRAlf are whole blood, packed red blood 
ce!Js, fresh frozen plasma, cryoprecipitate. platelet concentrates. apheresis platelets, and rarely IGIV , . 
The etioJogy of TRAU may be attributable to the prnence of aflti..HLA and/ or anti-granulocyte 
antibodies in the plasma cf multiparous females or donors who have received previous transfusion&. 
TRAU recipients have no specific demographics such as age, gender, or previous transfusion hiStory. 
Some investigators have hypothesized that TRAU is the result of two independent insults: patient 
clinical status and anti-white cell antibodies. Transfusion recipients who developTRALI '/rei have had a 
predisposing event such as surgery, active infection, mas&ive transfusion, or cytokine therapy that 
causes activation of the pulmonary endothelium and priming of the recipient's white blood cells 2. 
Although TRALI does not always occur thro:JP.r• trar.sfusions from donors with anti-HLA or anti-
granulocyte antibodies. one or both ofthese antibody types have been found in 89% ofTRALI cases. 3 
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1 Rizk A, Gorson K, Kenny L, and 'Weinstein R: Transfusion-related acute lung injury after the 
infusion of IVIG. Trandl$ion 2001; 41:264-268. 
2 Popovsky,MA. ChapUn, HC, and Moore, SB. Transfusion-relat9cllung injury: a negleCted 
serious compticaticn of hemotherapy. Transfusion 1992; 32:589-592. 
3 Silliman,C Transfusion-related acute lung injury. Transfusion 1999; 13:177-186. 
DiagnosiS and Treatment 
It appears that unlike allergic or anaphylactic immune-mediated transfusion reactions, antibodies 
impDcated in TRAJ..l are usually of donor origin. Once transferred to the recipient, these antioodies may 
cause complement activation resulting in neutrophilic influx into 1he lungs and damage to the 
pulmonary rricrovasculature. The clinical result may be subtle or significant_ In either case, there is 
typically a marl<ed hypoxemia, hypotension. fever, and severe bUateral pulmonary edema. Respiratcry 
support shoUld be as intensive as dictated by the clinical picture. Diuretics play no role in TRALI as the 
underlying pathology invclves micrQvascular injury, rather ihan fluid overload. 
Recommendations 
1. Be alert that any respiratory distress occurring during or following blood or blood component(s) 
transfusion could potentially be TRAU. Discontinue the transfusion immediately. Begin oxygen 
and supportive therapy. 
2. Notify the Blood Center that supplied the blood component and return remaining product to be 
tested fer anti·HLA and/or anti-granulocyte antibodies in the donor. 
3. Fatalities from TRALI should be reported tD CSER in accordance With 21CFR 606.170(b}. FDA 
encourages voluntary reporting ofTRALI as a serious adverse reaction to transfusions. Reports 
can be filed via MecMBtch by phone at 1-eQO.FOA-1088, by fax at 1..SOO-FDA-0178, by us mail 
at Med\IVatch, HF-2, 5600 F'IShers Lane, Rockville, MD 20852, or by email at 
httc;/Jwww.fda.ge~~r:madwatch. 
For More lnfonnation 
lf you have Questions regarding this alert, please contact Or. Leslie Holness, Center for Biologics 
Evaluaticn and Research, FDA, 1401 Rockville Pike, Mail Step HFM·375, Rockville, MD 20852.:1448, 
by fait at 301-827 ·3:34, or by e-man at !:I.QLNESS@cber. fda.gov. 
Sincerely, 
Kathryn C. Zoon, Ph.D. 
Director 
Center for Biologics Evaluation and Research 




NEWS FROM THE LffiRARY. 
OVID Instruction 
Contact Barb Iobst at 610-402-8408 to arrange for instruction 
in the use of OVID's MEDLINE and its other databases. 
Announcing New Online Full-text Products. 
Several new online full-text products are available from any 
workstation that has access to the L VHHN INTRANET home 
page. When at the home page, select "*Departments*" then 
"Clinical," and pick one of the following from the list: 
"The Medical Letter" - Information regarding anthrax was 
available in the last two issues. 
"Books@ Ovid" is a new entry in the list of databases 
available to L VHHN from "Ovid Online:" 
You can access the following Lippincott books using "Ovid 
Online": 
Scott: "Danforth's Obstetrics and Gynecology," 8th ed. 1999. 
Sadock: "Kaplan's & Sadock's Comprehensive Textbook of 
Psychiatry," 7th ed. 2000. 
Goroll:"Primary Care Medicine," 4th ed. 2000. 
Hume:"Kelley's Textbook oflnternal Medicine," 4th ed. 2000. 
__ : "Drug Facts & Comparison,"- Pocket Version. 2001. 
While in "Ovid Online," don't forget to try L VHHN's free trial 
subscription to "Evidence Based Medicine." 
New Library Publications. 
CC & 1-78 Site 
''Pediatric and Adolescent Gynecology," 2nd edition. 
"Multiple Organ Failure: Pathophysiology, Prevention, and 
Therapy" 
"Rosen's Breast Pathology," 2nd edition. 
1 
Computer-Based Training (CBT): 
Computer Based Training ( CBT) programs are available for 
L VHHN staff. Topics covered by the CBT programs include: 
Access 2.0 Power-Point 4.0 
Windows NT 4 Word 97 
Excel 97 Access 97 
PowerPoint 97 Lotus 1-2-3 Millennium 
WordPerfect 8 E-mail GUI 
PHAMIS LastW ord Inquiry Only commands 
'-
CBT programs replace the instructor-led classes previously 
held at Lehigh Valley Hospital. A proctor will be in the room 
with the learner while he/she takes the CBT, but the learner 
will control the pace and objectives of the learning. 
Computer Based Training takes place in Suite 401 of the 
John & Dorothy Morgan Cancer Center (the computer 
training room) and in the Muhlenberg Hospital Center 
computer training room (off the front lobby). The schedule 
ofupcoming dates is as follows: 
CBT sessions for JDMCC, suite 401 are as follows: 
December 18, noon - 4pm 
January 8, Sam- noon 
February 12, noon- 4pm 
March 26, Sam - noon 
April 23, Sam- noon 
Sessions at MHC, I.S. Training room are as follows: 
March 5, noon- 4pm 
May 14, noon-4pm 
Twelve slots are available for each session. 
To register, please contact Suzanne Rice via e-mail or at 610-
402-2475 with the following: 
date of session 
second date choice 
department 
phone number 
You will receive an e-mail confuming your choice within two 
business days. If you have any questions, please contact Craig 
Koller at 610-402-2413 or through e-mail. 
Center for Educational De11elopment and Support 
Presents the following Educational Activities: 
ETHICAL ISSUES IN PAIN MANAGEMENT 
A Satellite Teleconference from The University of Vermont 
Thursday, December 6, 2001 
1:30-3:30 PM 
Classroom #2- Cedar Crest & 1-78 
VTC Room - 17th & Chew Sts. 
On a daily basis, health care professionals face pain management dilemmas 
that involve serious ethical considerations. The questions surrounding this 
issue are complex & often the answers have been hard to find. 
Using an interdisciplinary approach, this compelling program analyzes the 
real-life ethical challenges that providers confront in the course of doing 
what's best for their patients. 
This two-hour program offers a forum to explore the ethical questions 
surrounding pain management and provides a framework for tackling the most 
common dilemmas faced in everyday practice. Learn the concepts necessary 
to help you address critical medical ethical issues. 
Program Overview: 
Under Treatment of Pain 
• Provider bias and beliefs: barriers & constraints 
• Fear of criminal prosecution 
• Misconceptions concerning addiction & tolerance 
Drug Addiction and Diversion 
• Definition of addiction & pseudo-addiction 
• Dependence & tolerance issues 
• Drug diversion & its impact on pain treatment practices 
Ethical Principles and Decision Making 
• Developing a knowledge base & self awareness 
• Applying ethical principles & pain management knowledge 
• Generating solutions in consultation with the patient 
Ethical Obligations of Providers 
• Accountability for pain relief 
• Pain prevention, assessment & treatment 
• Assuring institutional & clinical standards 
Presenters: 
Benjamin W. Moulton, J.D., M.P.H. 
Executive Director, American Society of Law, 
Medicine and Ethics, Boston, MA 
Myra J. Christopher 
President and CEO, Midwest Bioethics Center, 
Kansas City, MO 
Robert Orr, MD 
Director of Clinical Ethics, Fletcher Allen Health 
Care, Burlington, VT 
Rodney Bolejack, D.Min. 
Chaplain, VistaCare Family Hospice, Temple, TX 
John Coleman, MA, MS 
Drug Enforcement Administration, Assistant 
Administrator (Retired), Clifton, VA 
Moderator: Portland Helmich 
2 
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Host, Vermont Public Television, Burlington, VT 
Continuing Education Credits: 
The University of Vermont programs are designed to meet the continuing 
education needs of health care professionals. Nursing Contact Hours, 
Continuing Medical Education Credits & Nursing Home Administration 
Contact Hours are available to this teleconference. Please note, continuing 
education credit is available to participants viewing the event live via satellite 
only. Credit is not available for viewing the videotape. 
To register: 
Advanced registration is required since seating is limited. 
Using E-mail: 
--Please access the Bulletin Board entitled Forms_Nursing. 
--Select the Cont. Education Registration Form. 
-Right click on the form and choose "Use Form". 
- Complete all areas (refer to "How To Register" for more help on using 
forms). 
- Indicate which site you will be attending. 
-- Use the comments section to provide us with any additional information 
that may be useful. 
-We will be unable to process incomplete registrations. 
Using Phone or FIIX: 
--Please either can (610-402-2277) or fax (610-402-2203) the following 
information: name, hospital affiliation, position, mailing address, social 
security#, daytime phone#, and day attending. We will be unable to process 
incomplete registrations. 
PRECEPTOR PROGRAM 
Educational program for RN's who will be assigned responsibility to orient 
new staff to their clinical unit. 
Date 







-Please access the Bunetin Board entitled Forms_Nursing. 
-Select the Cont. Education Registration Form. 
-Right click on the form and choose "Use Form". 
-Complete an areas (refer to "How To Register" for more help on using 
forms). 
-- Indicate which day you will be attending. 
- Use the comments section to provide us with any additional information 
that may be useful. 
-We will be unable to process incomplete registrations. 
For stlljJwithout e-mail access. •• 
-Please either call (610-402-2277) or fax (610-402-2203) the following 
information: name, hospital affiliation, position, mailing address, social 
security#, daytime phone#, and day attending. We will be unable to process 
incomplete registrations. 
If you have any questions, please call the Center for Education at 610-402-
2277. 
Any questions, concerns or comments on articles from CEDS, please contact 
Bonnie Schoeneberger 610-402-2584 
December 
Sun Mon Tue Wed 
2 I 3 4 5 
12 noon Colon/Rectal TB 7am Family Practice GR- 12 noon MHC TB OR 
JDMCCCRI JDMCC IA/B Conf. Rm 
7am Surgical GR CC-Aud 
Sam Pediatric GR CC-Aud 
12 noon Medical GR CC-
Aud 
9 10 11 12 
7am Surgical GR CC-Aud 12 noon MHC TB OR 
Bam Pediatric GR CC-Aud Conf. Rm 
12 noon Medical GR CC-
Aud 
16 I 17 18 19 
12 noon Colon/Rectal TB 7am Surgical GR CC-Aud 12 noon MHC TB OR 
JDMCCCRI Sam Pediatric GR CC-Aud Conf.Rm 
12 noon Medical GR CC-
Aud 
23 24 25 26 




Bam Emergency Medicine 
GR L VH-CC Aud 
12 noon Combined TB 
JDMCCCRI 
13 
Bam Emergency Medicine 
GR L VHM-4'h Fl ConfRm 
12 noon GI TB JDMCC 
CRI 
20 
Bam Emergency Medicine 
GR L VHM 41k Fl ConfRm 
12 noon ENTTB JDMCC 
CRt 
27 





7am GYN GR CC CRI 
II am Neurology Conf CC 
Crt 
12 noon Breast TB JDMCC 
CRI 
14 I 15 
7am OBGYN GR CC CRI 
II am Neurology Conf CC 
Crt 
12 noon Breast TB JDMCC 
CRl 
21 I 22 
7am OBGYN GR CC CRI 
12 noon Breast TB JDMCC 
CRt 
28 I 29 
7am OBGYN GR CC CRI 
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